Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Lyme Disease Not Predictor of Long-Term Physical, Mental Health Issues

Lara C. Pullen, PhD  |  May 22, 2015

Lyme disease is often considered a cause of chronic fatigue, pain and other incapacitating symptoms. This assumption stems from analyses of patients who seek retreatment for Lyme disease. However, a new study suggests that Lyme disease is not life altering in the long term for most patients. Specifically, patients with culture-confirmed Lyme disease have similar physical and mental health as the general U.S. population at 11–20 years post-diagnosis.

In a study published online April 17, 2015, in Clinical Infectious Diseases, researcher George P. Wormser, MD, professor of medicine at the New York Medical College in Valhalla, and colleagues report results from a questionnaire designed to evaluate the quality of life in patients with well-documented early Lyme disease who received annual follow-up.1 They used the 36-Item Short Form General Health Survey (SF-36) version 2 to evaluate outcomes in patients with Lyme disease one to two decades after diagnosis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Although the study enrolled 238 patients, only 100 returned to the study center during the time when the SF-36 was administered. Participants and non-participants had similar Lyme disease-related characteristics at study entry, such as the proportion who exhibited multiple erythema migrans (EM) skin lesions. The mean age of the participants was 64.9 years (range 42–86 years) at the time of the SF-36 assessment. The investigators found that the SF-36 summary scores of physical and mental health were virtually identical in the participating patients as in general population normative data.

Results in Context

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Approximately 70–80% of patients have EM as the earliest manifestation of Lyme disease. The study by Wormser et al focused on these patients, but did not include patients with extracutaneous manifestations of Lyme disease. Thus, the study did not specifically include (or exclude) patients with neuroborreliosis or late Lyme arthritis.

In a 2003 study in the American Journal of Medicine, Dr. Wormser and colleagues published data indicating that 10% of patients with culture-confirmed Lyme disease experienced persistent symptoms for more than one year after antibiotic therapy.2 They also reported that approximately 1% of patients met criteria for fibromyalgia 19 years after a diagnosis of Lyme disease, compared with 2–8% of the general U.S. population.3 Although it’s difficult to say definitely that Lyme disease is not involved in symptoms of fibromyalgia, data from recent studies suggest that it is not a major cause. This should reassure patients and physicians that early Lyme disease is not likely to cause life-long debilitation.

Patients with Hematological Malignancy

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsPain SyndromesResearch RheumSoft Tissue Pain Tagged with:FibromyalgiaLyme DiseaseoutcomeResearch

Related Articles
    David M. Phillips / Science Source

    Lyme Arthritis: Presentation, Diagnosis & Treatment

    July 18, 2019

    A 52-year-old man living in greater Boston with a history of hyper­tension presented at our rheumatology clinic with bilateral knee pain and swelling. He had been in his usual state of health until four months earlier when he developed right knee pain and swelling without an incipient trauma, which did not improve with non-steroidal anti-inflammatory…

    The Patient's Choice

    When Rheumatologists Are a Patient’s Second or Third Choice for Medical Opinion

    September 7, 2016

    Outside Exam Room No. 5, the chart rack was empty, so I assumed my new consult was late. Just in case, I looked back over my shoulder as I passed by the partially open door and glimpsed the lower half of a woman holding a three-ringed binder on her lap. I squinted and took a…

    Lyme Arthritis Treatment Protocols Critical as Lyme Disease Spreads

    August 15, 2018

    As Lyme disease and Lyme arthritis spread to new regions in North America, physicians may ned to become aware of their signs and symptoms. Allen C. Steere, MD, says “Lyme arthritis is more complicated to treat than other manifestations of the disease.” Here are some best practices for treating Lyme arthritis…

    Updated Clinical Practice Guidelines for Lyme Disease, Lyme Arthritis

    February 16, 2021

    A team of healthcare practitioners and researchers, spearheaded by the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN) and the ACR, has developed updated evidence-based clinical practice guidelines for the prevention, diagnosis and treatment of Lyme disease. The 2020 guidelines cover a wide variety of Lyme disease manifestations, including Lyme arthritis. Linda…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences